🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy of once daily dosing with SPARC's novel ophthalmic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06-10
Trial ID
NCT03927443
The goal of this clinical trial is to determine the safety, efficacy, and c...
Status
Completed
Location
Vance Thompson Vision
Start Date
2023-06-26
Trial ID
NCT06085352
Treatments Being Tested
The objective of this study is to evaluate tolerability, safety and efficac...
Status
Completed
Location
Dipartimento "Organi di Senso" Università La Sapienza- Policlinico Umberto I
Start Date
2015-06-26
Trial ID
NCT02507934
Treatments Being Tested
The primary objective is to determine the efficacy of ST266 eye drops in he...
Status
Terminated
Location
Trinity Research Group
Start Date
2022-04-27
Trial ID
NCT05066698
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of Dextenza fo...
Status
Completed
Location
Retina Vitreous Surgeons of Central New York, PC
Start Date
2020-01-03
Trial ID
NCT04462523
Treatments Being Tested
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160
A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolera...
Status
Active Not Recruiting
Location
Beverly Hills Institute of Ophthalmology
Start Date
2025-01-10
Trial ID
NCT06852768
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
To investigate the dose-response relationship of DE-104 ophthalmic solution...
Status
Completed
Location
Sall Research Medical Center
Start Date
2008-03
Trial ID
NCT00650338